Biohaven Pharmaceutical Holding Co Ltd.(BHVN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BHVN Biohaven Pharmaceutical Holding Co Ltd.

Closed 03-16 16:00:00 EDT

9.64

+0.06

+0.63%

盘后9.64

+0.000.00%

19:51 EDT

High9.96	Low9.55	Vol1.65M
Open9.73	D1 Closing9.58	Amplitude4.28%
Mkt Cap1.45B	Tradable Cap1.20B	Total Shares150.42M
T/O15.99M	T/O Rate1.33%	Tradable Shares124.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BHVN","market":"US","secType":"STK","nameCN":"Biohaven Pharmaceutical Holding Co Ltd.","latestPrice":9.64,"timestamp":1773691200000,"preClose":9.58,"halted":0,"volume":1652553,"hourTrading":{"tag":"盘后","latestPrice":9.64,"preClose":9.64,"latestTime":"19:51 EDT","volume":37255,"amount":358946.371,"timestamp":1773705099388,"change":0,"changeRate":0,"amplitude":0.012448},"delay":0,"changeRate":0.006263048016701514,"floatShares":124000000,"shares":150417084,"eps":-6.864787,"marketStatus":"Closed","change":0.06,"latestTime":"03-16 16:00:00 EDT","open":9.73,"high":9.9599,"low":9.55,"amount":15990763.8492,"amplitude":0.042787,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.864787,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1773734400000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1493870400000,"exchange":"NYSE","adjPreClose":9.58,"preHourTrading":{"tag":"盘前","latestPrice":9.9,"preClose":9.58,"latestTime":"09:27 EDT","volume":2232,"amount":21770.006183999998,"timestamp":1773667637582,"change":0.32,"changeRate":0.033403,"amplitude":0.049061},"postHourTrading":{"tag":"盘后","latestPrice":9.64,"preClose":9.64,"latestTime":"19:51 EDT","volume":37255,"amount":358946.371,"timestamp":1773705099388,"change":0,"changeRate":0,"amplitude":0.012448},"volumeRatio":0.528369,"impliedVol":0.9758,"impliedVolPercentile":0.2749},"requestUrl":"/m/hq/s/BHVN/tweets","defaultTab":"tweets","newsList":[{"id":"2619148719","title":"Biohaven Ltd. Announces Annual Shareholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2619148719","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619148719?lang=en_us&edition=fundamental","pubTime":"2026-03-14 04:56","pubTimestamp":1773435368,"startTime":"0","endTime":"0","summary":"Biohaven will hold its annual meeting on April 28, 2026 in Virgin Gorda, British Virgin Islands. Shareholders will vote on the election of three director nominees: Michael Heffernan, Irina Antonijevic, and Robert Hugin. The meeting will also include a vote to ratify Ernst & Young as Biohaven’s independent registered public accounting firm for the fiscal year ending December 31, 2026. In addition, shareholders will vote on an advisory proposal regarding compensation for Biohaven’s named executive officers.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biohaven Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nNDLtHfrS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","BHVN","LU1093756325.SGD","BK4139"],"gpt_icon":0},{"id":"2618919535","title":"Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), Biohaven Ltd. (BHVN) and Siemens Healthineers AG (OtherSEMHF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618919535","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618919535?lang=en_us&edition=fundamental","pubTime":"2026-03-11 15:20","pubTimestamp":1773213645,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Praxis Precision Medicines (PRAX – Research Report),...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-praxis-precision-medicines-prax-biohaven-ltd-bhvn-and-siemens-healthineers-ag-othersemhf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-praxis-precision-medicines-prax-biohaven-ltd-bhvn-and-siemens-healthineers-ag-othersemhf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BHVN","IE00B4R5TH58.HKD","BK4137","IE00BJJMRZ35.SGD","IE0009355771.USD","LU0128526141.USD","IE0002141913.USD","AG","IE00B2B36J28.USD","PRAX","BK4581","IE00BFTCPJ56.SGD","LU0889565916.HKD","BK4585","BK4139","LU1093756325.SGD","XLV","LU0029874061.USD","LU1093756168.USD","BK4588","IE00BJT1NW94.SGD","BK4210","XBI","LU0109394709.USD","LABU","HCSG","LU0320765992.SGD"],"gpt_icon":0},{"id":"1165103273","title":"Stock Track | Biohaven Pharmaceutical Soars 5.14% Intraday on Positive Competitor Drug Data","url":"https://stock-news.laohu8.com/highlight/detail?id=1165103273","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165103273?lang=en_us&edition=fundamental","pubTime":"2026-03-10 03:34","pubTimestamp":1773084889,"startTime":"0","endTime":"0","summary":"Biohaven Pharmaceutical Holding Co Ltd. (BHVN) experienced a significant intraday surge of 5.14% on Monday.The sharp rise is attributed to positive clinical trial data released by competitor Xenon...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["BHVN"],"gpt_icon":0},{"id":"2618765716","title":"Raymond James says rival readout gives Biohaven’s Opakalim room to differentiate","url":"https://stock-news.laohu8.com/highlight/detail?id=2618765716","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618765716?lang=en_us&edition=fundamental","pubTime":"2026-03-10 01:50","pubTimestamp":1773078626,"startTime":"0","endTime":"0","summary":"Raymond James keeps a Strong Buy rating on Biohaven (BHVN) shares following competitor Xenon Pharmaceuticals’ (XENE) top-line Phase 3 readout for K...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/raymond-james-says-rival-readout-gives-biohavens-opakalim-room-to-differentiate-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/raymond-james-says-rival-readout-gives-biohavens-opakalim-room-to-differentiate-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BGHQF748.EUR","LU2265009873.SGD","BK4585","BHVN","BK4139","XENE","BK4588","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","LU1093756168.USD","BK4127","LU0971096721.USD","LU1093756325.SGD","RJF","LU1804176565.USD","LU1363072403.SGD"],"gpt_icon":0},{"id":"2618783146","title":"Biohaven fractionally lower after Xenon reports azetukalner Phase 3 hit target","url":"https://stock-news.laohu8.com/highlight/detail?id=2618783146","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618783146?lang=en_us&edition=fundamental","pubTime":"2026-03-09 23:55","pubTimestamp":1773071709,"startTime":"0","endTime":"0","summary":"Shares of Biohaven (BHVN) were sharply higher in early trading, but have given up their gains and moved into negative territory during Monday morni...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biohaven-fractionally-lower-after-xenon-reports-azetukalner-phase-3-hit-target-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biohaven-fractionally-lower-after-xenon-reports-azetukalner-phase-3-hit-target-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1093756168.USD","BHVN","LU1093756325.SGD","BK4139"],"gpt_icon":0},{"id":"2618678855","title":"What's Going On With Biohaven Stock On Monday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2618678855","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618678855?lang=en_us&edition=fundamental","pubTime":"2026-03-09 23:47","pubTimestamp":1773071220,"startTime":"0","endTime":"0","summary":"Biohaven shares rose in premarket trading after Xenon's Phase 3 epilepsy study showed strong seizure reduction results.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/09/Richmond--Virginia--Usa---9-May-2019-Ill.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/09/Richmond--Virginia--Usa---9-May-2019-Ill.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/26/03/51133485/whats-going-on-with-biohaven-stock-on-monday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/03/51133485/whats-going-on-with-biohaven-stock-on-monday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU0266512473.USD","BK4217","BK4588","SMA","BK4138","LU0122376428.USD","LU0368265418.SGD","BK4139","LU0300736492.USD","BHVN","LU0266512127.USD","LU0170899867.USD","LU0300736062.USD","LU0456854461.SGD","LU1093756168.USD","BK4585","LU1093756325.SGD","LU0788109394.HKD","XENE","MPC","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"1112851597","title":"Stock Track | Biohaven Pharmaceutical Plummets 6.45% Intraday Amid Conflicting Analyst Ratings","url":"https://stock-news.laohu8.com/highlight/detail?id=1112851597","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112851597?lang=en_us&edition=fundamental","pubTime":"2026-03-09 21:44","pubTimestamp":1773063884,"startTime":"0","endTime":"0","summary":"Biohaven Pharmaceutical Holding Co Ltd. (BHVN) saw its shares plummet 6.45% during intraday trading on Monday, marking a significant decline for the healthcare stock.The sharp drop follows the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["BHVN"],"gpt_icon":0},{"id":"2618113086","title":"Analysts Conflicted on These Healthcare Names: Biohaven Ltd. (BHVN) and Atai Beckley N.V. (ATAI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618113086","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618113086?lang=en_us&edition=fundamental","pubTime":"2026-03-09 11:40","pubTimestamp":1773027620,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Biohaven Ltd. (BHVN – Research Report) and Atai Beckley N.V. (ATA...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-biohaven-ltd-bhvn-and-atai-beckley-n-v-atai-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-biohaven-ltd-bhvn-and-atai-beckley-n-v-atai-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","BK4137","BK4588","LU1093756325.SGD","LU0128526141.USD","BK4539","LU1093756168.USD","XLV","BK4585","BHVN","ATAI","LU0029874061.USD","XBI","BK4581","LABU","BK4139","BK4007"],"gpt_icon":0},{"id":"2616537331","title":"Biohaven Is Maintained at Neutral by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2616537331","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616537331?lang=en_us&edition=fundamental","pubTime":"2026-03-04 20:08","pubTimestamp":1772626080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BHVN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 04, 2026 07:08 ET (12:08 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","BHVN","BK4139","LU1093756168.USD"],"gpt_icon":0},{"id":"1129379880","title":"Stock Track | Biohaven Pharmaceutical Plummets 7.45% Intraday After BofA Lowers Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=1129379880","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129379880?lang=en_us&edition=fundamental","pubTime":"2026-03-03 22:57","pubTimestamp":1772549878,"startTime":"0","endTime":"0","summary":"Biohaven Pharmaceutical Holding Co Ltd. (BHVN) stock plummeted 7.45% during intraday trading on Tuesday, reflecting significant negative investor sentiment.The sharp decline followed analyst actions...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["BHVN"],"gpt_icon":0},{"id":"1182010133","title":"Stock Track | Biohaven Pharmaceutical Plunges 6.69% in Pre-Market After BofA Lowers Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=1182010133","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182010133?lang=en_us&edition=fundamental","pubTime":"2026-03-03 22:06","pubTimestamp":1772546805,"startTime":"0","endTime":"0","summary":"Biohaven Pharmaceutical Holding Co Ltd. (BHVN) experienced a significant pre-market plunge of 6.69% on Tuesday, following analyst actions from Bank of America.The sharp decline came after BofA...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["BHVN"],"gpt_icon":0},{"id":"2616325926","title":"Biohaven price target lowered to $14 from $15 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2616325926","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616325926?lang=en_us&edition=fundamental","pubTime":"2026-03-03 21:52","pubTimestamp":1772545925,"startTime":"0","endTime":"0","summary":"BofA analyst Jason Gerberry lowered the firm’s price target on Biohaven (BHVN) to $14 from $15 and keeps a Neutral rating on the shares. Biohaven’s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biohaven-price-target-lowered-to-14-from-15-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biohaven-price-target-lowered-to-14-from-15-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1093756325.SGD","LU1093756168.USD","BHVN","BK4139"],"gpt_icon":0},{"id":"2616340389","title":"RBC Raises Price Target on Biohaven to $23 From $22, Keeps Outperform, Speculative Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2616340389","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616340389?lang=en_us&edition=fundamental","pubTime":"2026-03-03 20:48","pubTimestamp":1772542130,"startTime":"0","endTime":"0","summary":"Biohaven (BHVN) has an average rating of overweight and mean price target of $20.67, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BHVN","LU1093756325.SGD","LU1093756168.USD","BK4139"],"gpt_icon":0},{"id":"2616347868","title":"RBC Capital Keeps Their Buy Rating on Biohaven Ltd. (BHVN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2616347868","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616347868?lang=en_us&edition=fundamental","pubTime":"2026-03-03 20:17","pubTimestamp":1772540263,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Leonid Timashev from RBC Capital maintained a Buy rating on Biohaven Ltd., with a price target of $23.00. The compa...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-keeps-their-buy-rating-on-biohaven-ltd-bhvn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-keeps-their-buy-rating-on-biohaven-ltd-bhvn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BHVN"],"gpt_icon":0},{"id":"2616415253","title":"Bank of America Securities Sticks to Their Hold Rating for Biohaven Ltd. (BHVN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2616415253","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616415253?lang=en_us&edition=fundamental","pubTime":"2026-03-03 19:17","pubTimestamp":1772536628,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Jason Gerberry from Bank of America Securities reiterated a Hold rating on Biohaven Ltd., with a price target of $1...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-sticks-to-their-hold-rating-for-biohaven-ltd-bhvn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-sticks-to-their-hold-rating-for-biohaven-ltd-bhvn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BAC","BHVN"],"gpt_icon":0},{"id":"2616671483","title":"Biohaven Ltd reports results for the quarter ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2616671483","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616671483?lang=en_us&edition=fundamental","pubTime":"2026-03-03 07:30","pubTimestamp":1772494251,"startTime":"0","endTime":"0","summary":"Biohaven Ltd reports results for the quarter ended September 30 - Earnings SummaryBiohaven Ltd BHVN.N reported a quarterly adjusted loss of $1.21 per share for the quarter ended September 30, higher t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nL8N3ZQ375:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHVN","BK4139","LU1093756325.SGD","LU1093756168.USD"],"gpt_icon":0},{"id":"2616136915","title":"Biohaven Q4 net loss narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2616136915","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616136915?lang=en_us&edition=fundamental","pubTime":"2026-03-03 05:21","pubTimestamp":1772486481,"startTime":"0","endTime":"0","summary":"Biohaven Q4 net loss narrowsOverviewBiopharmaceutical company's Q4 net loss narrows to $145.6 mlnCompany raised $178.9 mln through common share sales after December 31, 2025Result DriversCOST OPTIMIZA","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nL1N3ZQ182:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHVN","LU1093756168.USD","LU1093756325.SGD","BK4139"],"gpt_icon":0},{"id":"2616369372","title":"Biohaven Q4 Adj. EPS $(1.21) Misses $(1.06) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2616369372","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616369372?lang=en_us&edition=fundamental","pubTime":"2026-03-03 05:16","pubTimestamp":1772486208,"startTime":"0","endTime":"0","summary":"Biohaven (NYSE:BHVN) reported quarterly losses of $(1.21) per share which missed the analyst consensus estimate of $(1.06) by 14.15 percent. This is a 29.24 percent increase over losses of $(1.71) per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/50984207/biohaven-q4-adj-eps-1-21-misses-1-06-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Biohaven Q4 Adj. EPS $(1.21) Misses $(1.06) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHVN","BK4139","LU1093756168.USD","LU1093756325.SGD"],"gpt_icon":0},{"id":"2616369977","title":"Biohaven reports Q4 adjusted EPS (90c), consensus (96c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2616369977","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616369977?lang=en_us&edition=fundamental","pubTime":"2026-03-03 05:15","pubTimestamp":1772486150,"startTime":"0","endTime":"0","summary":"Vlad Coric, M.D., Chairman and CEO of Biohaven (BHVN), commented, “We made significant progress over the past year in advancing our pipeline of inn...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biohaven-reports-q4-adjusted-eps-90c-consensus-96c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biohaven-reports-q4-adjusted-eps-90c-consensus-96c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1093756168.USD","BHVN","BK4139","LU1093756325.SGD"],"gpt_icon":0},{"id":"2616366499","title":"Biohaven Q4 net loss hits USD 145.6 million, R&D expenses fall 27.2% to USD 121.9 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2616366499","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616366499?lang=en_us&edition=fundamental","pubTime":"2026-03-03 05:06","pubTimestamp":1772485609,"startTime":"0","endTime":"0","summary":"Biohaven Q4 net loss hits USD 145.6 million, R&D expenses fall 27.2% to USD 121.9 million               Biohaven reported a GAAP net loss of USD 145.6 million in Q4 2025 and a GAAP net loss attributab","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nNDL3z0Xwr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","BHVN","BK4139","LU1093756168.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biohaven.com","stockEarnings":[{"period":"1week","weight":-0.0343},{"period":"1month","weight":-0.1868},{"period":"3month","weight":-0.1691},{"period":"6month","weight":-0.3123},{"period":"1year","weight":-0.6605},{"period":"ytd","weight":-0.1515}],"compareEarnings":[{"period":"1week","weight":-0.015},{"period":"1month","weight":-0.0429},{"period":"3month","weight":-0.0286},{"period":"6month","weight":0.0074},{"period":"1year","weight":0.2011},{"period":"ytd","weight":-0.0288}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Biohaven Ltd., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with debilitating neurological and neuropsychiatric diseases in the United States. The company's pipeline products include BHV-7000, a potassium channel activator for the treatment of focal epilepsy; BHV-7010, a Kv7 channel modulator for the treatment of different neurological diseases; Troriluzole, a tripeptide prodrug that is in Phase 3 clinical trial for the treatment of neurological and neuropsychiatric illnesses; BHV-5500, a low-trapping glutamate N-methyl-D-aspartate receptor antagonist for neuropathic pain; and Verdiperstat, an oral myeloperoxidase inhibitor, which is in Phase 3 clinical trial for the treatment of neurodegenerative diseases. It also offers Taldefgrobep Alfa, an anti-myostatin adnectin, which is in Phase 3 clinical trial for the treatment of spinal muscle atrophy; and BHV-1100 that is in Phase 1a/1b clinical trial for multiple myeloma patients. The company was formerly known as Biohaven Research Ltd and changed its name to Biohaven Ltd. in September 2022. Biohaven Ltd. was incorporated in 2022 and is headquartered in New Haven, Connecticut. Biohaven Ltd. is a subsidiary of Biohaven Pharmaceutical Holding Company Ltd.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.071849},{"month":2,"riseRate":0.222222,"avgChangeRate":-0.026101},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.109737},{"month":4,"riseRate":0.5,"avgChangeRate":0.0146},{"month":5,"riseRate":0.625,"avgChangeRate":0.144142},{"month":6,"riseRate":0.555556,"avgChangeRate":0.056007},{"month":7,"riseRate":0.555556,"avgChangeRate":0.010799},{"month":8,"riseRate":0.666667,"avgChangeRate":0.043364},{"month":9,"riseRate":0.777778,"avgChangeRate":0.09598},{"month":10,"riseRate":0.555556,"avgChangeRate":-0.072057},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.042561},{"month":12,"riseRate":0.555556,"avgChangeRate":0.054983}],"exchange":"NYSE","name":"Biohaven Pharmaceutical Holding Co Ltd.","nameEN":"Biohaven Pharmaceutical Holding Co Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Biohaven Pharmaceutical Holding Co Ltd.(BHVN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Biohaven Pharmaceutical Holding Co Ltd.(BHVN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Biohaven Pharmaceutical Holding Co Ltd.,BHVN,Biohaven Pharmaceutical Holding Co Ltd.股票,Biohaven Pharmaceutical Holding Co Ltd.股票老虎,Biohaven Pharmaceutical Holding Co Ltd.股票老虎国际,Biohaven Pharmaceutical Holding Co Ltd.行情,Biohaven Pharmaceutical Holding Co Ltd.股票行情,Biohaven Pharmaceutical Holding Co Ltd.股价,Biohaven Pharmaceutical Holding Co Ltd.股市,Biohaven Pharmaceutical Holding Co Ltd.股票价格,Biohaven Pharmaceutical Holding Co Ltd.股票交易,Biohaven Pharmaceutical Holding Co Ltd.股票购买,Biohaven Pharmaceutical Holding Co Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Biohaven Pharmaceutical Holding Co Ltd.(BHVN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Biohaven Pharmaceutical Holding Co Ltd.(BHVN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}